JP2019520038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520038A5 JP2019520038A5 JP2018554562A JP2018554562A JP2019520038A5 JP 2019520038 A5 JP2019520038 A5 JP 2019520038A5 JP 2018554562 A JP2018554562 A JP 2018554562A JP 2018554562 A JP2018554562 A JP 2018554562A JP 2019520038 A5 JP2019520038 A5 JP 2019520038A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cancer
- cell receptor
- peptide according
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021114872A JP2021181442A (ja) | 2016-04-21 | 2021-07-12 | 黒色腫およびその他のがんに対する免疫療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662325773P | 2016-04-21 | 2016-04-21 | |
| GB1606919.7 | 2016-04-21 | ||
| US62/325,773 | 2016-04-21 | ||
| GB201606919 | 2016-04-21 | ||
| PCT/EP2017/059016 WO2017182395A1 (en) | 2016-04-21 | 2017-04-13 | Immunotherapy against melanoma and other cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021114872A Division JP2021181442A (ja) | 2016-04-21 | 2021-07-12 | 黒色腫およびその他のがんに対する免疫療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520038A JP2019520038A (ja) | 2019-07-18 |
| JP2019520038A5 true JP2019520038A5 (enExample) | 2020-05-07 |
Family
ID=58579156
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554562A Pending JP2019520038A (ja) | 2016-04-21 | 2017-04-13 | 黒色腫およびその他のがんに対する免疫療法 |
| JP2021114872A Pending JP2021181442A (ja) | 2016-04-21 | 2021-07-12 | 黒色腫およびその他のがんに対する免疫療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021114872A Pending JP2021181442A (ja) | 2016-04-21 | 2021-07-12 | 黒色腫およびその他のがんに対する免疫療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10435455B1 (enExample) |
| JP (2) | JP2019520038A (enExample) |
| CL (3) | CL2018002969A1 (enExample) |
| CO (1) | CO2018012294A2 (enExample) |
| CR (3) | CR20180551A (enExample) |
| IL (1) | IL262503A (enExample) |
| MX (1) | MX2018012758A (enExample) |
| PH (1) | PH12018502159A1 (enExample) |
| SG (1) | SG10202006117QA (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014133568A1 (en) | 2013-03-01 | 2014-09-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing enriched populations of tumor reactive t cells from peripheral blood |
| GB201408100D0 (en) * | 2014-05-07 | 2014-06-18 | Sec Dep For Health The | Detection method |
| GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
| CA3112427A1 (en) | 2018-10-19 | 2020-04-23 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| CN114174323B (zh) * | 2019-07-05 | 2025-01-07 | 弗朗西斯·克里克研究所有限公司 | 新的癌抗原和方法 |
| CN115244173A (zh) | 2019-12-20 | 2022-10-25 | 英研生物(英国)有限公司 | 用于分离肿瘤浸润淋巴细胞的装置及方法及其用途 |
| CN117529492A (zh) * | 2021-01-21 | 2024-02-06 | 鹿特丹伊拉斯谟大学医疗中心 | 用于治疗的t细胞 |
| CN119943275B (zh) * | 2024-12-13 | 2026-02-17 | 南方医科大学南方医院 | 神经酰胺在预测肝细胞癌微血管侵犯风险中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001053312A1 (en) | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| CA2343602A1 (en) | 2000-04-18 | 2001-10-18 | Genset | Est's and encoded human proteins |
| EP1578371A4 (en) | 2002-08-19 | 2009-05-20 | Genentech Inc | COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT |
| US8088976B2 (en) | 2005-02-24 | 2012-01-03 | Monsanto Technology Llc | Methods for genetic control of plant pest infestation and compositions thereof |
| ATE461215T1 (de) | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| US20080107668A1 (en) | 2006-08-30 | 2008-05-08 | Immunotope, Inc. | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| EP1961825A1 (en) * | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Method for predicting the occurrence of metastasis in breast cancer patients |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| US20140073535A1 (en) * | 2011-05-12 | 2014-03-13 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| EP2834259A4 (en) | 2012-04-02 | 2016-08-24 | Moderna Therapeutics Inc | MODIFIED POLYNUCLEOTIDES |
| GB201411037D0 (en) | 2014-06-20 | 2014-08-06 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL) |
-
2017
- 2017-04-13 SG SG10202006117QA patent/SG10202006117QA/en unknown
- 2017-04-13 CR CR20180551A patent/CR20180551A/es unknown
- 2017-04-13 MX MX2018012758A patent/MX2018012758A/es unknown
- 2017-04-13 CR CR20200607A patent/CR20200607A/es unknown
- 2017-04-13 CR CR20200608A patent/CR20200608A/es unknown
- 2017-04-13 JP JP2018554562A patent/JP2019520038A/ja active Pending
-
2018
- 2018-10-08 PH PH12018502159A patent/PH12018502159A1/en unknown
- 2018-10-18 CL CL2018002969A patent/CL2018002969A1/es unknown
- 2018-10-21 IL IL262503A patent/IL262503A/en unknown
- 2018-11-14 CO CONC2018/0012294A patent/CO2018012294A2/es unknown
-
2019
- 2019-07-05 US US16/503,882 patent/US10435455B1/en active Active
- 2019-07-05 US US16/503,901 patent/US10519216B2/en active Active
-
2020
- 2020-12-18 CL CL2020003292A patent/CL2020003292A1/es unknown
- 2020-12-18 CL CL2020003293A patent/CL2020003293A1/es unknown
-
2021
- 2021-07-12 JP JP2021114872A patent/JP2021181442A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520038A5 (enExample) | ||
| JP2019516663A5 (enExample) | ||
| JP2019536426A5 (enExample) | ||
| JP2019513005A5 (enExample) | ||
| JP2020198875A5 (enExample) | ||
| JP2019515650A5 (enExample) | ||
| JP2019502360A5 (enExample) | ||
| JP2020506690A5 (enExample) | ||
| JP2020516681A5 (enExample) | ||
| AR121383A2 (es) | Péptidos y combinación de péptidos y andamiajes para su uso en inmunoterapia contra carcinoma de células renales (rcc) y otros cánceres | |
| JP2021101700A5 (enExample) | ||
| HRP20202019T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raka jajnika i drugih malignih tumora | |
| JP2019511214A5 (enExample) | ||
| JP2011520436A5 (enExample) | ||
| RU2020113032A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2019506838A5 (enExample) | ||
| JP2019515653A5 (enExample) | ||
| JP2018509936A5 (enExample) | ||
| JP2018529320A5 (enExample) | ||
| JP2017525336A5 (enExample) | ||
| JP2016501829A5 (enExample) | ||
| FI3273986T3 (fi) | Uusia peptidejä ja peptidien yhdistelmiä käytettäväksi immunoterapiassa eri syöpiä vastaan | |
| JP2019530441A5 (enExample) | ||
| JP2020516313A5 (enExample) | ||
| AR110857A1 (es) | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer |